Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001628280-23-013216
Filing Date
2023-04-26
Accepted
2023-04-26 16:02:35
Documents
4
Period of Report
2023-04-26

Document Format Files

Seq Description Document Type Size
1 6-K innatepharma-6xksalesagree.htm 6-K 21272
2 EX-1.1 innatepharmaex11-6xksalesa.htm EX-1.1 365078
3 EX-5.1 innatepharmaex51-6xksalesa.htm EX-5.1 35830
4 image_1a.jpg GRAPHIC 37070
  Complete submission text file 0001628280-23-013216.txt   474378
Mailing Address 117 AVENUE DE LUMINY BP 30191 MARSEILLE I0 13009
Business Address 117 AVENUE DE LUMINY BP 30191 MARSEILLE I0 13009 33430303030
Innate Pharma SA (Filer) CIK: 0001598599 (see all company filings)

EIN.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39084 | Film No.: 23849636
SIC: 2836 Biological Products, (No Diagnostic Substances)